gabapentin has been researched along with Prostatic Neoplasms in 7 studies
Gabapentin: A cyclohexane-gamma-aminobutyric acid derivative that is used for the treatment of PARTIAL SEIZURES; NEURALGIA; and RESTLESS LEGS SYNDROME.
gabapentin : A gamma-amino acid that is cyclohexane substituted at position 1 by aminomethyl and carboxymethyl groups. Used for treatment of neuropathic pain and restless legs syndrome.
Prostatic Neoplasms: Tumors or cancer of the PROSTATE.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Via a prospective, double-blind, placebo-controlled clinical trial, men with hot flashes, on a stable androgen deprivation therapy program for prostate cancer, received a placebo or gabapentin at target doses of 300, 600, or 900 mg/day." | 9.14 | A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). ( Atherton, PJ; Barton, DL; Bearden, JD; Dueck, AC; Fitch, TR; Jafar, S; Khoyratty, BS; Knutson, WH; Kottschade, L; Loprinzi, CL; Marsa, GW; Rowland, KM, 2009) |
| "To report a case of successful treatment of refractory hot flashes with gabapentin in a patient with prostate cancer who was receiving combination antiandrogen and gonadotropin hormone-releasing hormone (GnRH) analog therapy." | 7.71 | Gabapentin for hot flashes in prostate cancer. ( Jeffery, SM; Pepe, JJ; Popovich, LM; Vitagliano, G, 2002) |
| "Via a prospective, double-blind, placebo-controlled clinical trial, men with hot flashes, on a stable androgen deprivation therapy program for prostate cancer, received a placebo or gabapentin at target doses of 300, 600, or 900 mg/day." | 5.14 | A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB). ( Atherton, PJ; Barton, DL; Bearden, JD; Dueck, AC; Fitch, TR; Jafar, S; Khoyratty, BS; Knutson, WH; Kottschade, L; Loprinzi, CL; Marsa, GW; Rowland, KM, 2009) |
| "To report a case of successful treatment of refractory hot flashes with gabapentin in a patient with prostate cancer who was receiving combination antiandrogen and gonadotropin hormone-releasing hormone (GnRH) analog therapy." | 3.71 | Gabapentin for hot flashes in prostate cancer. ( Jeffery, SM; Pepe, JJ; Popovich, LM; Vitagliano, G, 2002) |
| "The breadth of literature for the treatment of hot flashes is much smaller in men than that in women." | 2.48 | Androgen deprivation therapy-associated vasomotor symptoms. ( Jones, JM; Kohli, M; Loprinzi, CL, 2012) |
| "Women treated for breast cancer and men receiving androgen ablation for prostate cancer experience hot flushes that are more frequent, severe and longer lasting than those experienced by the general menopausal population." | 2.43 | Treatment of hot flushes in breast and prostate cancer. ( Adelson, KB; Hershman, DL; Loprinzi, CL, 2005) |
| "5 mg/d, are reasonable initial dosages, and if symptoms do not improve within a week or two, the dosage can be doubled." | 2.42 | Management of hot flashes in breast cancer survivors and men with prostate cancer. ( Stearns, V, 2004) |
| "The Dunning rat model of prostate cancer was used." | 1.43 | Gabapentin, an Analgesic Used Against Cancer-Associated Neuropathic Pain: Effects on Prostate Cancer Progression in an In Vivo Rat Model. ( Altun, S; Bugan, I; Djamgoz, MB; Karagoz, Z, 2016) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (57.14) | 29.6817 |
| 2010's | 3 (42.86) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bugan, I | 1 |
| Karagoz, Z | 1 |
| Altun, S | 1 |
| Djamgoz, MB | 1 |
| Loprinzi, CL | 3 |
| Dueck, AC | 1 |
| Khoyratty, BS | 1 |
| Barton, DL | 1 |
| Jafar, S | 1 |
| Rowland, KM | 1 |
| Atherton, PJ | 1 |
| Marsa, GW | 1 |
| Knutson, WH | 1 |
| Bearden, JD | 1 |
| Kottschade, L | 1 |
| Fitch, TR | 1 |
| Jones, JM | 1 |
| Kohli, M | 1 |
| Lefkowits, CC | 1 |
| Arnold, RM | 1 |
| Stearns, V | 1 |
| Adelson, KB | 1 |
| Hershman, DL | 1 |
| Jeffery, SM | 1 |
| Pepe, JJ | 1 |
| Popovich, LM | 1 |
| Vitagliano, G | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Phase III Randomized, Double-Blind, Placebo-Controlled Trial of Gabapentin in the Management of Hot Flashes in Men[NCT00028574] | Phase 3 | 223 participants (Actual) | Interventional | 2001-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for gabapentin and Prostatic Neoplasms
| Article | Year |
|---|---|
Androgen deprivation therapy-associated vasomotor symptoms.
Topics: Amines; Androgen Antagonists; Anticonvulsants; Antidepressive Agents; Cyclohexanecarboxylic Acids; F | 2012 |
Management of hot flashes in breast cancer survivors and men with prostate cancer.
Topics: Amines; Anti-Anxiety Agents; Breast Neoplasms; Complementary Therapies; Contraceptives, Oral, Synthe | 2004 |
Treatment of hot flushes in breast and prostate cancer.
Topics: Amines; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cimicifuga; Contraindications; Cyclohexan | 2005 |
1 trial available for gabapentin and Prostatic Neoplasms
| Article | Year |
|---|---|
A phase III randomized, double-blind, placebo-controlled trial of gabapentin in the management of hot flashes in men (N00CB).
Topics: Aged; Aged, 80 and over; Amines; Androgen Antagonists; Cyclohexanecarboxylic Acids; Dose-Response Re | 2009 |
3 other studies available for gabapentin and Prostatic Neoplasms
| Article | Year |
|---|---|
Gabapentin, an Analgesic Used Against Cancer-Associated Neuropathic Pain: Effects on Prostate Cancer Progression in an In Vivo Rat Model.
Topics: Amines; Analgesics; Animals; Carcinogenesis; Cells, Cultured; Cyclohexanecarboxylic Acids; Disease M | 2016 |
Hot flashes in palliative care. Part 2 #262.
Topics: Amines; Analgesics; Antineoplastic Agents, Hormonal; Breast Neoplasms; Clonidine; Cyclohexanecarboxy | 2013 |
Gabapentin for hot flashes in prostate cancer.
Topics: Acetates; Aged; Amines; Androgen Antagonists; Cyclohexanecarboxylic Acids; Excitatory Amino Acid Ant | 2002 |